ICT-01(Imcheck Therapeutics)

N/A

Report date: 2026/04/08 16:01:21

Base Information

Drug NameICT-01(Imcheck Therapeutics)
Drug Alias NameICT-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Butyrophilin subfamily 3 member A1
TargetsButyrophilin subfamily 3 member A1
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImCheck Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesImCheck Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A